what's the difference between glp 1 and glp 2 Comparing Ozempic, Wegovy Other GLP-1 Drugs Main physiological actions of the

If Phase 3 results confirm its safety and efficacy, it could reach the market within the next 12 years

Though modest, it was statistically significant, reinforcing that GLP-1 RAs provide cardiovascular benefit even in a broad diabetes population

It gained popularity for its once-weekly dosing schedule, something that most other GLP-1 receptor agonists now match

10.1210/jc.2004-1979 88 MatsenM

A 2025 real-world analysis of Wegovy users found that extending the titration phase by 4-8 weeks significantly reduced nausea-related discontinuation without meaningfully affecting 52-week weight loss outcomes

And the nutrient gap is only part of the problem